Building for Change: Technologies, Modalities

Moderator(s)

• 

  Jennifer Vance, PhD (she/her/hers)

  Director, Bioanalytical and Biomarker Development
  Recursion Pharmaceuticals
  Salt Lake City, Utah

Presentations:

• 8:05 AM - 8:30 AM ET

  Overcoming Assay Challenges for a Monoclonal Antibody Reversal Agent
  

  Speaker: Joshua Zylstra, PhD – Regeneron Pharmacuticals
• 8:30 AM - 8:55 AM ET

  A Comprehensive Cellular Kinetics Strategy to Inform T-cell Therapy Programs
  

  Speaker: Sebastian Guelman, PhD (he/him/his) – Genentech, Inc.
• 8:55 AM - 9:20 AM ET

  Fit-for-purpose Approaches to Support Immunogenicity Assessment of Multivalent Bispecific Antibodies
  

  Speaker: Bob Liu, PhD (he/him/his) – Genentech, Inc.
• 9:20 AM - 9:45 AM ET

  Flow Cytometry: A Quantitative Science!
  

  Speaker: Virginia Litwin, PhD (she/her/hers) – Eurofins Clinical Trial Solutions
• 10:05 AM - 10:30 AM ET

  Exploring the Regulatory Landscape: Focus on qPCR and Bioanalytical Applications
  

  Speaker: Amanda L. Hays, PhD – BioAgilytix
• 10:30 AM - 10:55 AM ET

  Ligand Binding Methodologies for the Assessment of Pharmacodynamics and Immunogenicity of an mRNA-LNP Therapeutic Encoding for Multiple Proteins
  

  Speaker: Matthew R. Moore (he/him/his) – Moderna
• 11:10 AM - 11:55 AM ET

  Building for Change: Technologies, Modalities: Panel Discussion
  

  Speaker: Joshua Zylstra, PhD – Regeneron Pharmacuticals

  Speaker: Sebastian Guelman, PhD (he/him/his) – Genentech, Inc.

  Speaker: Bob Liu, PhD (he/him/his) – Genentech, Inc.

  Speaker: Amanda L. Hays, PhD – BioAgilytix

  Moderator: Jennifer A. Vance, PhD (she/her/hers) – Recursion Pharmaceuticals

  Speaker: Virginia Litwin, PhD (she/her/hers) – Eurofins Clinical Trial Solutions

  Speaker: Matthew R. Moore (he/him/his) – Moderna

  Rapid Fire Presenter: Soumya Mohana Sundaram, M.S. – Celerion
• 11:55 AM - 12:00 PM ET

  Closing Remarks
  

  Moderator: Jennifer A. Vance, PhD (she/her/hers) – Recursion Pharmaceuticals